Literature DB >> 32984910

Thyroid Hormone Signalling Alteration in Diabetic Nephropathy and Cardiomyopathy: a "Switch" to the Foetal Gene Programme.

Polyxeni Mantzouratou1, Angelo Michele Lavecchia1, Rubina Novelli1, Christodoulos Xinaris2,3.   

Abstract

PURPOSE OF THE REVIEW: In this study, we will analyse how diabetes induces the reactivation of organs' developmental programmes and growth, discuss how thyroid hormone (TH) signalling orchestrates these processes, and suggest novel strategies for exploiting TH-mediated reparative and regenerative properties. RECENT
FINDINGS: Diabetes is a global pandemic that poses an enormous threat to human health. The kidney and the heart are among the organs that are the most severely damaged by diabetes over time. They undergo profound metabolic, structural, and functional changes that may be due (at least partially) to a recapitulation of their early developmental programmes. There is growing evidence to suggest that this foetal reprogramming is controlled by the TH/TH receptor alpha 1 (TRα1) axis. We introduce the hypothesis that in diabetes-and probably in other diseases-TH signalling acts in an antagonistic manner: it recapitulates a foetal profile that is necessary to coordinate metabolic and structural adaptations to sustain energy preservation and growth, but in the long term the persistent changes in these pathways are detrimental.

Entities:  

Keywords:  Cardiomyocytes; Diabetic cardiomyopathy; Diabetic nephropathy; Foetal reprogramming; Podocytes; TRα1; Thyroid hormone signalling

Year:  2020        PMID: 32984910     DOI: 10.1007/s11892-020-01344-6

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  2 in total

Review 1.  Thyroid Hormone Signalling in Human Evolution and Disease: A Novel Hypothesis.

Authors:  Polyxeni Mantzouratou; Angelo Michele Lavecchia; Christodoulos Xinaris
Journal:  J Clin Med       Date:  2021-12-23       Impact factor: 4.241

2.  Association of Thyroid Hormone Levels with Microvascular Complications in Euthyroid Type 2 Diabetes Mellitus Patients.

Authors:  Yonghui Hu; Zhibo Hu; Wangna Tang; Wenjie Liu; Xiaoming Wu; Congqing Pan
Journal:  Diabetes Metab Syndr Obes       Date:  2022-08-12       Impact factor: 3.249

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.